ZELTIQ to Present at J.P. Morgan 33rd Annual Healthcare Conference

ZELTIQ to Present at J.P. Morgan 33rd Annual Healthcare Conference

ID: 364199

Investor Presentation Now Available on Corporate Website

(firmenpresse) - PLEASANTON, CA -- (Marketwired) -- 01/13/15 -- ZELTIQ®, (NASDAQ: ZLTQ) a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, CoolSculpting®, will present at the J.P. Morgan 33rd Annual Healthcare Conference tomorrow, Wednesday, January 14, 2015. President and Chief Executive Officer, Mark Foley, will present at 7:30 a.m. PT / 10:30 a.m. ET at the Westin St. Francis Hotel in San Francisco. A copy of ZELTIQ's investor presentation is available on the investor relations section of ZELTIQ's web site, at .

In anticipation of the event, the Company has posted its investor presentation under the Investor Relations section of ZELTIQ's website at . An audio webcast of the Company's presentation will be available by visiting the investor relations web site. A replay of the presentation will be available for 90 days.

ZELTIQ is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting® System, is designed to selectively reduce stubborn fat bulges. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed CoolSculpting to safely, noticeably, and measurably reduce the fat layer.






Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Christopher Homes Unveils New Model Homes At Azalea In Rosedale iSatori Launches Its Newest Patented Weight-Loss Pill -- DygloTrim(TM) With Dyglomera(R), Under the BioGenetics Brand, to Retail Stores Nationwide
Bereitgestellt von Benutzer: Marketwired
Datum: 14.01.2015 - 01:10 Uhr
Sprache: Deutsch
News-ID 364199
Anzahl Zeichen: 0

contact information:
Town:

PLEASANTON, CA



Kategorie:

Personal Care & Fitness



Diese Pressemitteilung wurde bisher 332 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"ZELTIQ to Present at J.P. Morgan 33rd Annual Healthcare Conference"
steht unter der journalistisch-redaktionellen Verantwortung von

ZELTIQ Aesthetics, Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

ZELTIQ Announces Location and Agenda for 2015 Investor Day ...

PLEASANTON, CA -- (Marketwired) -- 10/21/15 -- ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced the location an ...

ZELTIQ(R) Aesthetics Showcasing Its CoolMini(TM) Applicator ...

PLEASANTON, CA -- (Marketwired) -- 10/15/15 -- ZELTIQ® Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announce ...

Alle Meldungen von ZELTIQ Aesthetics, Inc.



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z